A fluorescent glycolipid-binding peptide probe traces cholesterol dependent microdomain-derived trafficking pathways

Area of Science:

• Cell Biology
• Biochemistry
• Neuroscience

Background:

• Sphingolipid trafficking is crucial in cellular processes and implicated in various diseases.
• Existing methods for tracking sphingolipids in live cells are limited.
• A novel sphingolipid-binding domain (SBD) peptide probe was developed for live-cell imaging.

Purpose of the Study:

• To characterize the sphingolipid-binding properties of the SBD peptide.
• To investigate the live-cell trafficking pathways of the SBD probe.
• To evaluate SBD as a tool for studying sphingolipid dynamics in disease models.

Main Methods:

• Developed a novel fluorescently labeled SBD peptide probe.
• Performed synthetic membrane binding assays to assess lipid specificity.
• Utilized quantitative time-course colocalization studies in live cells to track trafficking.

Main Results:

• SBD binding is dependent on sphingolipids and cholesterol, interacting with raft-like lipid mixtures.
• SBD exhibits a unique endolysosomal trafficking route distinct from other markers.
• SBD trafficking is sensitive to cholesterol perturbations, highlighting cholesterol's role in sphingolipid transport.

Conclusions:

• The SBD peptide is a novel, non-toxic probe for studying sphingolipid binding and trafficking.
• SBD's endolysosomal pathway and sensitivity to cholesterol make it valuable for disease research.
• This probe facilitates the analysis of sphingolipid metabolism in conditions involving cholesterol dysregulation.